This is a research study to evaluate the safety and effectiveness of tocilizumab in combination with atezolizumab to treat non-small cell lung cancer.

Lung Cancer, Nonsmall Cell

~Estimated

~$10 – $6,250

Abramson Cancer Center at Penn MedicineNCT04691817

I3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy

I3LUNG is an international project aiming to develop a medical device to predict immunotherapy efficacy for NSCLC patients using the integration of multisource…

Non Small Cell Lung CancerLung Cancer MetastaticLung Cancer, Nonsmall Cell+1 more

~Estimated

~$10 – $1,125

Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoNCT05537922

Predicting Immunotherapy Efficacy from Analysis of Pre-treatment Tumor Biopsies

This study will collect de-identified tumor samples, with correlated clinical/demographic data and tissue histology, from patients selected or scheduled for pr…

Cancer of Head and NeckLung Cancer, Nonsmall CellSmall-cell Lung Cancer+8 more

~Estimated

~$10 – $1,050

Cofactor Genomics, Inc.NCT04510129